| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |